An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer

MLA

Ronald D. Alvarez, et al. An Ex Vivo Assay of XRT-Induced Rad51 Foci Formation Predicts Response to PARP-Inhibition in Ovarian Cancer. May 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....141bf961fcce30583023cf0d72c41e07&authtype=sso&custid=ns315887.

APA

Ronald D. Alvarez, Monica E. Wielgos, Eddy S. Yang, Panagiotis A. Konstantinopoulos, Zachary C. Dobbin, Charles N. Landen, Somaira Nowsheen, Ashwini A. Katre, & Monjri Shah. (2014). An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer.

Chicago

Ronald D. Alvarez, Monica E. Wielgos, Eddy S. Yang, Panagiotis A. Konstantinopoulos, Zachary C. Dobbin, Charles N. Landen, Somaira Nowsheen, Ashwini A. Katre, and Monjri Shah. 2014. “An Ex Vivo Assay of XRT-Induced Rad51 Foci Formation Predicts Response to PARP-Inhibition in Ovarian Cancer,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....141bf961fcce30583023cf0d72c41e07&authtype=sso&custid=ns315887.